Reborn Coffee Provides Third Quarter 2024 Corporate Update and Financial Results
- Interim report: January – March 2025 - April 23, 2025
- VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies - April 23, 2025
- Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS) - April 23, 2025